Related Experiment Video
Updated: May 27, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
The nuclear epidermal growth factor receptor signaling network and its role in cancer
Toni M Brand1, Mari Iida, Chunrong Li
1Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, 1111 Highland Ave., WIMR 3159, Madison, Wisconsin 53705, USA.
Abstract:
The epidermal growth factor receptor (EGFR) is a member of the EGFR family of receptor tyrosine kinases (RTKs). EGFR activation via ligand binding results in signaling through various pathways ultimately resulting in cellular proliferation, survival, angiogenesis, invasion, and metastasis. Aberrant expression or activity of EGFR has been strongly linked to the etiology of several human epithelial cancers including but not limited to head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), breast cancer, pancreatic cancer, and brain cancer. Thus intense efforts have been made to inhibit the activity of EGFR by designing antibodies against the ligand binding domains (cetuximab and panitumumab) or small molecules against the tyrosine kinase domain (erlotinib, gefitinib, and lapatinib). Although targeting membrane-bound EGFR has shown benefit, a new and emerging role for EGFR is now being elucidated. In this review we will summarize the current knowledge of the nuclear EGFR signaling network, including how it is trafficked to the nucleus, the functions it serves in the nucleus, and how these functions impact cancer progression, survival, and response to chemotherapeutics.
Insights
This review explores the nuclear functions of the epidermal growth factor receptor (EGFR). Understanding nuclear EGFR signaling is crucial for developing new cancer therapies and improving patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK) involved in cell signaling.
- Aberrant EGFR activity is linked to various epithelial cancers, leading to targeted therapies.
- Emerging research highlights a novel role for EGFR within the cell nucleus.
Purpose of the Study:
- To review current knowledge on the nuclear EGFR signaling network.
- To elucidate the mechanisms of nuclear EGFR trafficking.
- To understand the impact of nuclear EGFR functions on cancer progression and treatment response.
Main Methods:
- Literature review of existing research on EGFR.
- Analysis of studies detailing EGFR nuclear localization and function.
- Synthesis of data on EGFR's role in cancer pathways.
Main Results:
- EGFR is trafficked to the nucleus, where it regulates distinct signaling pathways.
- Nuclear EGFR influences cancer progression, cell survival, and metastasis.
- EGFR's nuclear functions may affect response to existing chemotherapeutics.
Conclusions:
- The nuclear role of EGFR represents a significant area for cancer research.
- Targeting nuclear EGFR may offer novel therapeutic strategies.
- Further investigation into nuclear EGFR signaling is warranted for improved cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Signal Transduction: Overview
Typically, signal transduction involves three...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
